Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of inclusion-body myositis with IVIg

1 Mar 1997

Abstract excerpt

We randomized 19 patients with inclusion-body myositis (IBM) to a double-blind, placebo-controlled, crossover study using monthly infusions of 2 g/kg intravenous immunoglobulin (IVIg) or placebo for 3 months. Patients crossed over to the alternate treatment after a washout period. We evaluated responses at baseline and at the end of each treatment period using expanded (0-10) MRC scales, the Maximum Voluntary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Immune Cell Function and Interaction
Share to T-cell and B-cell Immunology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9065553
DOI: 10.1212/wnl.48.3.712

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Treatment of inclusion-body myositis with IVIgPMID 9065553Read ↗

Clinical heterogeneity based on race and sex within a large cohort of inclusion body myositis patientsSemantic proximity Read ↗

Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.Semantic proximity Read ↗

Inclusion Body MyositisSemantic proximity Read ↗

Inclusion body myositis: A review of clinical and genetic aspects, diagnostic criteria and therapeutic approachesSemantic proximity Read ↗

Classification of myositis.Semantic proximity Read ↗

Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.Semantic proximity Read ↗

Immune and myodegenerative pathomechanisms in inclusion body myositisSemantic proximity Read ↗

MODERN ASPECTS OF ETIOPATHOGENESIS, DIAGNOSIS, CLINICAL COURSE AND TREATMENT OF SPORADIC INCLUSION BODY MYOSITIS.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.